EQT to Acquire Molecular Testing Firm Qiagen for $10.8 Billion
Sweden's EQT agreed to acquire Qiagen for €9.6 billion ($10.78 billion), valuing the molecular testing firm at $12.1 billion. The transaction is expected to close in mid-2027, leading Qiagen to suspen
reuters · 2026-10-21 14:47 UTC